LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis

Biosci Rep. 2019 Nov 29;39(11):BSR20190445. doi: 10.1042/BSR20190445.

Abstract

The functions of long (>200 nt) non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) have only been investigated in cancer biology. We found that plasma LncRNA SNHG1 was down-regulated in postmenopausal than in premenopausal females. Among postmenopausal females, the ones with postmenopausal osteoporosis showed much lower expression levels of plasma lncRNA SNHG1. A 6-year follow-up study on postmenopausal females revealed that plasma lncRNA SNHG1 decreased in females with postmenopausal osteoporosis but not in healthy postmenopausal females. Levels of plasma lncRNA SNHG1 at 12 months before diagnosis is sufficient to distinguish postmenopausal osteoporosis patients from healthy controls. After treatment, plasma lncRNA SNHG1 were significantly up-regulated. Therefore, lncRNA SNHG1 was down-regulated after menopause and plasma level of lncRNA SNHG1 may serve as a biomarker for the diagnosis and treatment of postmenopausal osteoporosis.

Keywords: diagnosis; lncRNA SNHG1; postmenopausal osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Down-Regulation / genetics*
  • Female
  • Follow-Up Studies
  • Humans
  • Menopause / genetics*
  • Middle Aged
  • Osteoporosis, Postmenopausal / genetics*
  • RNA, Long Noncoding / genetics*
  • Up-Regulation / genetics

Substances

  • RNA, Long Noncoding
  • long non-coding RNA SNHG1, human